151 related articles for article (PubMed ID: 24010978)
1. Effect of ganciclovir for the treatment of severe cytomegalovirus-associated pneumonia in children without a specific immunocompromised state.
Doan TT; Phung TT; Pham HV; Pham SH; Nguyen LT
BMC Infect Dis; 2013 Sep; 13():424. PubMed ID: 24010978
[TBL] [Abstract][Full Text] [Related]
2. Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation.
Ju HY; Kang HJ; Hong CR; Lee JW; Kim H; Park KD; Shin HY; Park JD; Choi EH; Lee HJ; Ahn HS
Transpl Infect Dis; 2016 Jun; 18(3):396-404. PubMed ID: 27041364
[TBL] [Abstract][Full Text] [Related]
3. Ganciclovir therapy in two immunocompetent infants with severe acquired CMV pneumonitis.
Suresh N; Thiruvengadam V
Paediatr Int Child Health; 2013 Feb; 33(1):46-8. PubMed ID: 23485496
[TBL] [Abstract][Full Text] [Related]
4. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir.
Höcker B; Zencke S; Krupka K; Fichtner A; Pape L; Dello Strologo L; Guzzo I; Topaloglu R; Kranz B; König J; Bald M; Webb NJ; Noyan A; Dursun H; Marks S; Yalcinkaya F; Thiel F; Billing H; Pohl M; Fehrenbach H; Bruckner T; Tönshoff B
Transplantation; 2016 Apr; 100(4):862-70. PubMed ID: 26736017
[TBL] [Abstract][Full Text] [Related]
6. Dose and duration-dependence of ganciclovir treatment against murine cytomegalovirus infection in severe combined immunodeficient mice.
Duan J; Paris W; Kibler P; Bousquet C; Liuzzi M; Cordingley MG
Antiviral Res; 1998 Oct; 39(3):189-97. PubMed ID: 9833959
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
8. Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics.
Caldés A; Gil-Vernet S; Armendariz Y; Colom H; Pou L; Niubó J; Lladó L; Torras J; Manito N; Rufí G; Grinyó JM
Transpl Infect Dis; 2010 Jun; 12(3):204-12. PubMed ID: 20002612
[TBL] [Abstract][Full Text] [Related]
9. The effect of topical application of 0.15% ganciclovir gel on cytomegalovirus corneal endotheliitis.
Koizumi N; Miyazaki D; Inoue T; Ohtani F; Kandori-Inoue M; Inatomi T; Sotozono C; Nakagawa H; Horikiri T; Ueta M; Nakamura T; Inoue Y; Ohashi Y; Kinoshita S
Br J Ophthalmol; 2017 Feb; 101(2):114-119. PubMed ID: 27142389
[TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus pneumonia in an immunocompetent patient: a very uncommon but treatable condition.
Waqas QA; Abdullah HMA; Khan UI; Oliver T
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31451465
[TBL] [Abstract][Full Text] [Related]
11. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children.
Nigro G; Krzysztofiak A; Bartmann U; Clerico A; Properzi E; Valia S; Castello M
Arch Virol; 1997; 142(3):573-80. PubMed ID: 9349303
[TBL] [Abstract][Full Text] [Related]
12. Congenital Cytomegalovirus Pneumonitis and Treatment Response Evaluation Using Viral Load during Ganciclovir Therapy: a Case Report.
Lee-Yoshimoto M; Goishi K; Torii Y; Ito Y; Ono H; Mori T; Kashiwa N; Hosokawa S; Shichino H
Jpn J Infect Dis; 2018 Jul; 71(4):309-311. PubMed ID: 29709989
[TBL] [Abstract][Full Text] [Related]
13. Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation.
Park GE; Ki HK; Ko JH
BMC Infect Dis; 2021 May; 21(1):414. PubMed ID: 33947335
[TBL] [Abstract][Full Text] [Related]
14. [Different dosages Ganciclovir treatment of symptomatic congenital cytomegalovirus infection in neonatal].
Hong-Bin Z; Feng-Xian Z; Cai-Ping G
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):57-9. PubMed ID: 22919757
[TBL] [Abstract][Full Text] [Related]
15. CMV pneumonia in allogeneic BMT recipients undergoing early treatment of pre-emptive ganciclovir therapy.
Machado CM; Dulley FL; Boas LS; Castelli JB; Macedo MC; Silva RL; Pallota R; Saboya RS; Pannuti CS
Bone Marrow Transplant; 2000 Aug; 26(4):413-7. PubMed ID: 10982288
[TBL] [Abstract][Full Text] [Related]
16. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
[TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDS.
Brosgart CL; Louis TA; Hillman DW; Craig CP; Alston B; Fisher E; Abrams DI; Luskin-Hawk RL; Sampson JH; Ward DJ; Thompson MA; Torres RA
AIDS; 1998 Feb; 12(3):269-77. PubMed ID: 9517989
[TBL] [Abstract][Full Text] [Related]
18. Treatment of active cytomegalovirus disease with oral ganciclovir in renal allograft recipients: monitoring efficacy with quantitative cytomegalovirus polymerase chain reaction.
Jordan SC; Vo A; Bunnapradist S; Toyoda M; Kamil E
Am J Transplant; 2002 Aug; 2(7):671-3. PubMed ID: 12201370
[TBL] [Abstract][Full Text] [Related]
19. Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group.
Frenkel LM; Capparelli EV; Dankner WM; Xu J; Smith IL; Ballow A; Culnane M; Read JS; Thompson M; Mohan KM; Shaver A; Robinson CA; Stempien MJ; Burchett SK; Melvin AJ; Borkowsky W; Petru A; Kovacs A; Yogev R; Goldsmith J; McFarland EJ; Spector SA
J Infect Dis; 2000 Dec; 182(6):1616-24. PubMed ID: 11069232
[TBL] [Abstract][Full Text] [Related]
20. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
Iwasenko JM; Scott GM; Ziegler JB; Rawlinson WD
J Clin Virol; 2007 Oct; 40(2):152-5. PubMed ID: 17698411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
